{"id":"W2339149872","doi":"10.1200/jco.2015.64.3171","title":"Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: TEXT and SOFT Trials","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":182,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada); Boehringer Ingelheim (Canada)","funders":"National Cancer Institute; Cancer Research UK","keywords":"Exemestane; Medicine; Tamoxifen; Breast cancer; Oncology; Internal medicine; Population; Gynecology; Estrogen receptor; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004981362,0.0005331204,0.001511034,0.0004366336,0.0001634285,0.0007432469,0.0003786146,0.0009248979,0.004094714],"category_scores_gemma":[0.00985696,0.0001892251,0.002104754,0.0003538715,0.0004232276,0.0007227579,0.0004398373,0.001025614,0.0002687228],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003083804,"about_ca_system_score_gemma":0.0003589756,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002666624,"about_ca_topic_score_gemma":0.000747146,"domain_scores_codex":[0.9975062,0.001791297,0.0002426471,0.0002091551,0.0001894921,0.00006115475],"domain_scores_gemma":[0.9939644,0.003908823,0.001353837,0.0002893684,0.0001844825,0.0002990446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.8474507,0.001558977,0.02019549,0.004298496,0.01140664,0.00006820205,0.0001013362,0.001665519,0.004294289,0.0005016103,0.001322152,0.1071367],"study_design_scores_gemma":[0.5155992,0.2382389,0.1775519,0.001816307,0.04257252,0.000393766,0.0002145291,0.005969763,0.006748708,0.003165675,0.007635989,0.00009273962],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9641111,0.0275358,0.0009847201,0.001133631,0.0002638113,0.0007797157,0.001303889,0.00005633126,0.003831082],"genre_scores_gemma":[0.9937021,0.002376034,0.0008827474,0.0007472549,0.000326061,0.0003134729,0.000727554,0.000007355673,0.0009174114],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004981362,"threshold_uncertainty_score":0.0263443,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05678427435732385,"score_gpt":0.3879864615385772,"score_spread":0.3312021871812534,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}